575 related articles for article (PubMed ID: 34054927)
1. Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing.
Duan L; Ouyang K; Xu X; Xu L; Wen C; Zhou X; Qin Z; Xu Z; Sun W; Liang Y
Front Genet; 2021; 12():673286. PubMed ID: 34054927
[TBL] [Abstract][Full Text] [Related]
2. Lipid-, Inorganic-, Polymer-, and DNA-Based Nanocarriers for Delivery of the CRISPR/Cas9 system.
Song N; Chu Y; Tang J; Yang D
Chembiochem; 2023 Aug; 24(16):e202300180. PubMed ID: 37183575
[TBL] [Abstract][Full Text] [Related]
3. Delivery of CRISPR/Cas9 for therapeutic genome editing.
Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
5. Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems.
Hejabi F; Abbaszadeh MS; Taji S; O'Neill A; Farjadian F; Doroudian M
Front Chem; 2022; 10():957572. PubMed ID: 36092658
[TBL] [Abstract][Full Text] [Related]
6. Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.
Li L; Hu S; Chen X
Biomaterials; 2018 Jul; 171():207-218. PubMed ID: 29704747
[TBL] [Abstract][Full Text] [Related]
7. Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing.
Kim D; Le QV; Wu Y; Park J; Oh YK
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33353099
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications.
Cheng H; Zhang F; Ding Y
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683943
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles: The game-changer in CRISPR-Cas9 genome editing.
Mohammadian Farsani A; Mokhtari N; Nooraei S; Bahrulolum H; Akbari A; Farsani ZM; Khatami S; Ebadi MS; Ahmadian G
Heliyon; 2024 Jan; 10(2):e24606. PubMed ID: 38288017
[TBL] [Abstract][Full Text] [Related]
10. A CRISPR/Cas9 based polymeric nanoparticles to treat/inhibit microbial infections.
Verma R; Sahu R; Singh DD; Egbo TE
Semin Cell Dev Biol; 2019 Dec; 96():44-52. PubMed ID: 30986568
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
12. [Research progress of CRISPR-Cas9 system for gene therapy].
Zhan C; Xia X
Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
14. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
[TBL] [Abstract][Full Text] [Related]
15. Delivering the CRISPR/Cas9 system for engineering gene therapies: Recent cargo and delivery approaches for clinical translation.
Foley RA; Sims RA; Duggan EC; Olmedo JK; Ma R; Jonas SJ
Front Bioeng Biotechnol; 2022; 10():973326. PubMed ID: 36225598
[TBL] [Abstract][Full Text] [Related]
16. Development of CRISPR/Cas Delivery Systems for In Vivo Precision Genome Editing.
Chen Y; Ping Y
Acc Chem Res; 2023 Aug; 56(16):2185-2196. PubMed ID: 37525893
[TBL] [Abstract][Full Text] [Related]
17.
Kayesh MEH; Hashem MA; Kohara M; Tsukiyama-Kohara K
Front Microbiol; 2022; 13():953218. PubMed ID: 35847068
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in stimuli-responsive polymeric carriers for controllable CRISPR/Cas9 gene editing system delivery.
Ma P; Wang Q; Luo X; Mao L; Wang Z; Ye E; Loh XJ; Li Z; Wu YL
Biomater Sci; 2023 Jul; 11(15):5078-5094. PubMed ID: 37282836
[TBL] [Abstract][Full Text] [Related]
19. Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy.
Wang L; Zheng W; Liu S; Li B; Jiang X
Chembiochem; 2019 Mar; 20(5):634-643. PubMed ID: 30393919
[TBL] [Abstract][Full Text] [Related]
20. Recent Progress in CRISPR/Cas9 Technology.
Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
